Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02922153 · ClinicalTrials.gov registry record · NA
The cryoICE™ CryoAnalgesia Study For Pain Management in Post thoRacic Procedures Via intercOSTal Cryoanalgesia (FROST)
A NA study of Pain, sponsored by AtriCure.
- Completed
- Registry status
- NA
- Development phase
- 84
- Enrollment target
- 5
- Study locations
NCT02922153: Completed NA study of Pain, sponsored by AtriCure.
NCT02922153 is a NA study of Pain that has completed, run by AtriCure. The registered enrollment target is 84 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (72% lower). The trial reports 5 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02922153, a NA study of Pain, has completed, sponsored by AtriCure.
- COMPLETED
- Registry status
- NA
- Development phase
- 84 participants
- Enrollment target
- 5
- Study locations
Study Summary
The investigators propose to assess whether intra-operative intercostal cryoanalgesia using the cryoICE® probe (AtriCure®, Inc., 7555 Innovation Way, Mason, Ohio) provides superior post-operative analgesic efficacy as compared to current pain management in patients undergoing unilateral thoracotomy cardiac procedures.
Primary Outcome
Forced Expiratory Volume (FEV1) is the measurement of how much air, in volume, that a person can exhale with a forced breath. It is measured using a spirometer device.
Conditions Studied
Interventions
- DRUG Standard of Care
- DEVICE Cryoanalgesia
Study Locations (5)
Michigan
- University of Michigan - Ann Arbor
- William Beaumont Hospital - Royal Oak
California
- University of Southern California (USC) - Los Angeles
Minnesota
- United Heart and Vascular Institute - Allina - Saint Paul
Ohio
- Cleveland Clinic - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2016-06-13 |
| Est. Completion | 2019-08-28 |
| Phase | NA |
What the finished NCT02922153 record still lists
NCT02922153 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 84 participants, a relatively small participant target, below the 304-participant average among 374 other Pain trials with a reported enrollment target (72% lower).
The record links to 1 condition, with Pain appearing as the primary indexed condition, and to 2 interventions - of which Standard of Care is the first listed.
NCT02922153 lists 5 locations in 4 states (Michigan, California, Minnesota).
Frequently Asked Questions
What is clinical trial NCT02922153 about?
NCT02922153 is a clinical study titled "The cryoICE™ CryoAnalgesia Study For Pain Management in Post thoRacic Procedures Via intercOSTal Cryoanalgesia (FROST)". The investigators propose to assess whether intra-operative intercostal cryoanalgesia using the cryoICE® probe (AtriCure®, Inc., 7555 Innovation Way, Mason, Ohio) provides superior post-operative analgesic efficacy as compared to current pain management in patients undergoing unilateral thoracotomy ...
What is the current status of trial NCT02922153?
This trial is currently completed. It is a NA study. The enrollment target is 84 participants. The study started on 2016-06-13. Estimated completion is 2019-08-28.
What conditions does trial NCT02922153 study?
This clinical trial studies the following conditions: Pain.
What interventions are being tested in trial NCT02922153?
The interventions under investigation include: Standard of Care (DRUG), Cryoanalgesia (DEVICE).
Who is sponsoring clinical trial NCT02922153?
This trial is sponsored by AtriCure, which has 23 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02922153 being conducted?
This trial has 5 study locations across California, Michigan, Minnesota, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02922153's enrollment target sits among peer trials
84 188th of 374 higher than 184 of 374 other Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Postoperative Pain After Activation of Irrigant
RECRUITING · NA
-
Neural Mechanisms of Immersive Virtual Reality in Chronic Pain (VR TMD EEG)
RECRUITING · NA
-
Pain With Dementia
RECRUITING · NA
-
Oklahoma Study of Native American Pain Risk IV: Smoking Cessation and Pain
RECRUITING · NA
-
Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain
RECRUITING · NA
-
TENS Analgesia During Outpatient Urethral Bulking for Stress Urinary Incontinence.
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02391519 · 84 participants
Effects of High Altitude on AMPK Activation
- NCT03838536 · 84 participants · NA
Synergistic Activity of Human Milk Nutrients and Infant Cognition
- NCT03884075 · 84 participants · Phase 2
Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)
- NCT03894917 · 84 participants
Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI